Three strands of UAE evidence explain why botanical products meet a receptive market. The first is familiarity. In a 2022 national online survey of 448 adults across the seven emirates, 98.7% of participants reported using herbal medicines; the most common reasons were enhancing immunity (26.8%) and relaxation (23.5%).[1] The sample was a convenience sample and 70.3% female, so the figure shows how ordinary herbal use is among those surveyed, not a population prevalence.
The second is broad supplement use. In a 2026 survey of 600 adults, 47.8% had ever used dietary supplements, and 58.9% of those were current users.[2] Vitamins (70.6%), minerals (57.8%) and protein (47.4%) were the categories users reported most, so herbal products compete with a market that is led by vitamins and minerals.
The third is cultural continuity. A 2025 review describes Traditional Emirati Medicine as a living body of plant-based and other practices that still needs research on efficacy, safety and quality.[4] Many residents also come from South Asia and other regions where traditional medicine is part of everyday health care, which is where interest in Ayurvedic supplements starts. None of the studies cited here separates Ayurvedic products from herbal use in general. A 2023 review of the UAE nutrition situation, which reports high obesity and diabetes prevalence alongside scarce micronutrient data, supplies the wider preventive-health backdrop.[5]
Peer-reviewed studies measure behaviour, not revenue. Table 1 shows what each one can and cannot support in a business case for herbal supplements in the UAE.
Table 1. UAE evidence on herbal and supplement use
| Study | Sample and method | Key finding | What it tells brands | Limit |
|---|---|---|---|---|
| Herbal medicine use, 2022[1] | 448 adults, online survey, convenience sample, 7 emirates | 98.7% used herbal medicines; immunity (26.8%) and relaxation (23.5%) the main reasons | Herbal use is ordinary; immunity is a leading motive | Not representative; 70.3% female; COVID-era context |
| Dietary supplement use, 2026[2] | 600 adults, online survey, convenience sample | 47.8% had ever used supplements; 58.9% of those were current users | About half of adults sampled are existing or past users | “Ever used” is not current use; herbal not among the top three categories |
| Supplement disclosure (SIDP-12), 2024[6] | 407 adults, online survey; 137 took supplements | Most respondents were not asked about supplements by hospital or community pharmacists | Users may not tell clinicians what they take, so labels must carry clear cautions | A disclosure tool, not a sales measure |
Read together, the figures are directional: herbal use is common and many adults are not yet supplement users. That is the opening for a well-registered, well-documented product. This guide deliberately quotes no market size. Commercial estimates differ by definition, year and method, and none could be traced to a primary or peer-reviewed source, so any sizing figure needs its definition and method stated before it enters a business case.
In the UAE, the route a product can take decides what it can be, what it can say and where it can be sold. Two published frameworks matter for herbal supplements:
Dubai Municipality’s guideline also lists banned or not-applicable ingredients in Annex 3. Several well-known Ayurvedic botanicals are on it, including ashwagandha (Withania somnifera), amla (Phyllanthus emblica), arjuna (Terminalia arjuna), punarnava (Boerhavia diffusa), gurmar (Gymnema sylvestre) and shilajit.[3] Turmeric (Curcuma longa) is not listed. For brands, this is the most important demand-side fact in this guide: an ingredient that sells well elsewhere may not be registrable as a Dubai health supplement at all, so confirm the route for each botanical before you build a range around it. Our sibling guide on herbal supplement claims in the UAE covers the wording rules.
No UAE study cited here ranks herbal ingredients by sales, so Table 2 is a development priority list, not a sales ranking.
Table 2. Ingredient priorities and the question behind each
| Ingredient group | Why it matters for UAE development | Key technical or regulatory question |
|---|---|---|
| Turmeric and curcumin | Well known, not on Dubai Municipality’s banned list, and absorption-enhanced formats differentiate[3][8] | Which delivery format, and what evidence supports any absorption claim for the finished product |
| Ashwagandha and other Ayurvedic adaptogens | Strong demand in other markets (see our ashwagandha study explainer) | Ashwagandha is on Dubai Municipality’s banned or not-applicable list for health supplements; confirm whether any route is open before development[3] |
| Immunity botanicals | Immunity was the most cited reason for herbal use in one UAE survey[1] | Dubai Municipality allows “supports the immune system” type functional claims but prohibits disease-prevention claims such as “protects the body against diseases”[3] |
Formulator’s note: check the claim and the ingredient list before the formula. A banned botanical or a medical-sounding immunity message can push a UAE product out of the supplement category altogether.
Whichever channel you choose, the buyer will expect a registration appropriate to the product’s category. Pharmacy sales add a conversation, but the SIDP-12 study found that most respondents had not been asked about supplements by hospital or community pharmacists, so the label has to do the work: state every ingredient, the daily dose and any caution about medicines clearly.[6]
Online sales carry the most risk for brands that skip registration. A marketplace listing is not a licence. In April 2019, the Ministry of Health and Prevention warned the public about a red yeast rice supplement promoted on social media with cholesterol and heart claims, stating that it was not licensed by the ministry.[9] Dubai Municipality’s claim rules also apply to advertisements and leaflets, not only to the label.[3] Our sibling article on lead and undeclared drugs in herbal supplement recalls shows what happens when quality and identity controls fail.
The UAE studies above do not measure the wider GCC supplements market, so this guide treats the region as a sequencing decision, not a sizing claim. Each GCC country runs its own registration system, so a UAE authorisation is one national step and extending it needs market-specific regulatory work. Brands usually start with one well-documented dossier and reuse its composition, stability and quality data for each additional market.
Four decisions follow from the evidence:
For the wider process, see our herbal product development hub and our guides to supplement label claims and overage in the UAE, private-label herbal supplements in India and herbal beverage development for the UAE.
Demand for herbal and Ayurvedic products in the UAE rests on widespread herbal use, broad adult supplement use and strong traditional roots, but the public evidence supports direction, not a sales figure. The decisive constraints are regulatory: Dubai excludes products presented as Ayurvedic or traditional medicine from its health supplement category and lists several Ayurvedic botanicals as banned or not applicable. Brands that choose ingredient, format, claim and registration route together will turn interest in herbal supplements into a product that can be sold.
Food Research Lab supports UAE and GCC brands from Chennai, India. Our herbal formulation team screens your ingredient list against the UAE route, develops the format and prepares the technical file, from composition and halal documentation to stability and claim review. Analytical, stability and contaminant testing are run or arranged through accredited partner laboratories.
See our herbal formulation services, our herbal product development sector page and our UAE market support, or speak to our regulatory and scientific research team. You can also contact us with your product idea.
This guide opens FRL’s UAE herbal and Ayurvedic supplement series. Read on in this order:
No reliable, sourced market value is available. Peer-reviewed UAE studies measure use, not sales: 98.7% of 448 participants in a 2022 online survey used herbal medicines, and 47.8% of 600 adults in a 2026 survey had ever used supplements. Any market figure needs a stated definition, year and method before it is used.
Many residents come from regions with long-established herbal traditions, and herbal use is widespread in UAE surveys. Ayurvedic products fit that familiarity, although no study cited here separates Ayurvedic use from herbal use overall. Note that Dubai Municipality treats products presented as Ayurvedic medicine as outside its health supplement category.
Not as a Dubai Municipality health supplement under the current guideline. Version 2 (May 2024) lists Withania somnifera (ashwagandha) in Annex 3, its banned or not-applicable ingredients, alongside amla, arjuna, punarnava, gurmar and shilajit. Brands should confirm with the authorities whether any other route is open before developing an ashwagandha product.
No UAE study ranks herbal ingredients by sales. Turmeric is a strong candidate because it is well known, is not on Dubai Municipality’s banned list and benefits from absorption-enhanced formats. Immunity was the most cited reason for herbal use in one survey, but immunity claims must stay within functional wording.
Yes. Dubai Municipality states that no health supplement may be imported, advertised, sold or distributed in Dubai unless it is registered in Montaji, and its claim rules cover advertisements as well as labels. A marketplace listing is not a licence, and the health ministry has publicly warned about unlicensed supplements sold online.
No. Each GCC country runs its own registration system, so a UAE authorisation is one national step. Extending to other GCC markets needs country-specific regulatory work, although a well-built dossier with composition, stability and quality data can be reused. The UAE studies cited here do not measure demand in other GCC countries.